Contractors / Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp

prime recipient of federal awards · UEI KABZK8W6PQT3 ✓ from source

$6.1B

obligated · FY2024

funding agencies

100%

from Defense

states

100%

in Pennsylvania

industries

Obligations by year

≈ computed

$4.4B

FY23

$6.1B

FY24

$7.4B

FY25

▲ 69%

since FY23

Where this money comes from

✓ from source

FUNDING AGENCIES

AMERISOURCEBERGEN DRUG C

Defense

$6.1B

3 other agencies

$0B

Amerisourcebergen Drug Corp

$6.1B

FY2024 obligated

band width = obligations · FY2024 · source: USASpending.gov

Biggest awards (total value)

No awards yet.

What it does (NAICS / PSC)

Medicinal and Botanical Manufacturing$4.1B

Drugs and Druggists' Sundries Merchant Wholesalers$2B

Refrigerated Warehousing and Storage$7.6M

In-Vitro Diagnostic Substance Manufacturing$4M

Pharmaceutical Preparation Manufacturing$541K

Where the work lands

Pennsylvania✓ from source$6.1B

Illinois✓ from source$501

Competitors

DMS Pharmaceutical Group Inc≈ computed$15.2M

Glaxosmithkline, LLC≈ computed$2.4M

Medline Industries, LP≈ computed$224.7K

Mckesson Corporation≈ computed$34.9K

Concordance Healthcare Solutions LLC≈ computed$33.3K

Alvogen, Inc.≈ computed$1.5K

Sanofi Vaccines US Inc.≈ computed$1.1K

computed from shared NAICS, not a stated rivalry.

Corporate family

Single registration: no combined family.

🔎

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.